Don't Expect Tresiba to Have Much Benefit Over Other Longer-Acting Insulins

Reps will promote Tresiba (treh-SEE-bah, insulin degludec), a new once-daily ULTRA long-acting insulin.

It lasts about 42 hours...compared to about 24 hours for Lantus or Levemir and a little over 24 hours for Toujeo.

You may hear that Tresiba's longer duration means it doesn't need to be used at the same time every day.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote